GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

6 Months Ended

Jun. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSETS CARRYING VALUE

			As of June 30, 2021			As of December 31, 2020
	Life		Carrying			Carrying
	(Years)		Amount			Amount
				(unaudited)
Asuragen acquisition:
Thyroid		9	$	8,519		$	8,519
RedPath acquisition:
Pancreas test		7		16,141			16,141
Barrett’s test		9		6,682			6,682
BioPharma acquisition:
Trademarks		10		1,600			1,600
Customer relationships		8		5,700			5,700
CLIA Lab		2.3	$	609		$	609
Total			$	39,251		$	39,251
Accumulated Amortization			$	(30,125	)	$	(27,900	)
Net Carrying Value			$	9,126		$	11,351

SCHEDULE OF FUTURE ESTIMATED AMORTIZATION EXPENSE

2021		2022		2023		2024		2025
$	4,078	$	2,155	$	2,099	$	873	$	873

SCHEDULE OF GOODWILL CARRYING VALUE

The following table displays a roll forward of the carrying amount of goodwill from December 31, 2020 to June 30, 2021:

	Carrying
	Amount
Balance as of December 31, 2020	$	8,433
Adjustments		-
Balance as of June 30, 2021	$	8,433